Ankur M. Shah, M.D.
Sub-Specialty:
Macula-Retina-Vitreous Services
Practice:
Raj K. Maturi, M.D., P.C.
317-817-1414
For Credit Card Payment
PracticeID: MEIRKM
Patient-Care Specialties
Clinical Trials:
Please visit: https://retinamidwest.com/participate-in-a-trial/
Diabetic retinopathy, Dry AMD, Wet AMD, Uveitis, Vein Occlusion & Genetic diseases
Diagnostic Services and Procedures
Ocular Coherence Tomography, Digital Photography, Fluorescein Angiography, OPTOS Ultra-wide field Angiography, Multifocal Electroretinography, Ganzfeld Electroretinography, B-Scan Ultrasonography
Intravitreal Injections, Retinal Laser Photocoagulation, Pneumatic Retinopexy, Cryoretinopexy, Vitreous, Macular and Retinal Surgery
Education
M.D. Northwestern University, Feinberg School of Medicine, Chicago, IL-2002 - 2006
Alpha Omega Alpha (AOA) Medical Honor Society, 2006
B.S. University of Michigan, Ann Arbor, MI-1998 - 2001
Biological Anthropology with Highest Distinction
Residency
Ophthalmology University of California - San Diego, Shiley Eye Center, San Diego, CA 2007 - 2010
Chief Resident University of California - San Diego, Shiley Eye Center, San Diego,CA 2009 - 2010
Fellowship
Surgical Retina University of Chicago, Chicago, IL
2014 - 2016
Medical Retina Northwestern University, Chicago, IL
2010 - 2011
Professional Affiliations
American Academy of Ophthalmology (AAO)
American Society of Retina Specialists (ASRS)
Association for Research in Vision and Ophthalmology (ARVO)
Club Vit
Research
Publications
Shah AM, Grewal D. Which treatment paradigm - local or systemic therapy - best treats bilateral noninfectious uveitis?
Point/Counter: Ocular Surgery News U.S. Edition, March 10, 2020
Gupta N, Shah AM, Jampol LM, Gill, MK. Intravitreal Bevacizumab for Choroidal Metastases Secondary to Adenocarcinoma of the Lung.
Clinical Communications - Oncology. 2015:2:2.
Shah AM, Bressler NM, Jampol LM. Does Laser Still Have a Role in the Management of Retinal Vascular and Neovascular Diseases?
American Journal of Ophthalmology 2011;152(3):332-339.
Shah AM, Oster SF, Freeman WR. Viral Retinitis After Intravitreal Triamcinolone Injection in Patients with Predisposing Medical Comorbidities.
American Journal of Ophthalmology 2010;149(3):433-440.
Abstracts and Presentations
"YUTIQ CALM: a real-world registry study of the fluocinolone acetonide intravitreal implant 0.18 mg in chronic non-infectious posterior uveitis." Shah AM. Presented at American Society of Retinal Specialists Annual Meeting. San Antonio, TX. October 9, 2021.
Intravitreal Bevacizumab for Choroidal Metastases Secondary to Adenocarcinoma of the Lung." Shah AM, Gill MK, Jampol LM. Presented at American Society of Retinal Specialists Annual Meeting. Boston, MA. August 22, 2011.
Viral Retinitis After Intravitreal Triamcinolone Injection in Patients with Predisposing Medical Comorbidities." Shah AM, Oster SF, Freeman WR. Presented at Shiley Eye Center Alumni Research Day, La Jolla, CA. June 19, 2010.
Principal Investigator Protocols
COAST, (OPT-3002-1005) A phase III, multicenter, double-masked, randomized study to evaluate the efficacy and safety of Intravitreal OPT-302 in combination with Aflibercept, compared with Aflibercept alone, in participants with Neovascular Age-Related Macular Degeneration, 2021
BALATON, (GR41984) A phase III, multicenter, randomized, double-masked, active comparator-controlled study to evaluate the efficacy and safety of Faricimab in patients with Macular Edema secondary to Branch Retinal Vein Occlusion, 2021
COMINO, (GR41986) A phase III, multicenter, randomized, double-masked, active comparator-controlled study to evaluate the efficacy and safety of Faricimab in patients with Macular Edema secondary to Central Retinal or Hemiretinal Vein Occlusion, 2021
AVONELLE-X, (GR42691) A multicenter, open-label extension study to evaluate the long-term safety and tolerability of Faricimab in patients with Neovascular Age-Related Macular Degeneration, 2021
THE NEW DAY STUDY, (01-20-005) A randomized, masked, controlled study of intravitreal Iluvien Implant as baseline therapy in patients with early Diabetic Macular Edema, 2020
RHONE-X, (GR41987) A multicenter, open-label extension study to evaluate the long-term safety and tolerability of Faricimab in patients with Diabetic Macule edema, 2020
NORSE III (ONS-5010-003) A 3-month study to assess the safety of ONS-5010 in subjects with visual impairment due to retinal disorders, 2020
PHOTON, (VGFTe-HD-DME-1934), A randomized, double-masked, active-controlled phase 2/3 study of the efficacy and safety of high-dose Aflibercept in patients with Diabetic Macular Edema, 2020
TALON, (CRTH258A2303), A 64-week, two-arm, randomized, double-masked, multicenter, phase III study assessing the efficacy and safety of Brolucizumab 6 mg compared to Aflibercept 2 mg in a treat-to-control regimen in patients with neovascular age-related macular degeneration, 2019
KINGFISHER, (RTH258B2305), A 12-month, 2-arm, randomized, double-masked, multicenter phase III study assessing the efficacy and safety of Brolucizumab every 4 weeks versus Aflibercept every 4 weeks in adult patients with visual impairment due to Diabetic Macular Edema, 2019
NORSE II, (ONS-5010-002), A clinical effectiveness, multicenter, randomized, double-masked, controlled study of the efficacy and safety of ONS-5010 in subjects with subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), 2019
LUCERNE, (GR40844), A phase III, multi-center, randomized, double-masked, active comparator-controlled study to evaluate the efficacy and safety of Faricimab in patients with neovascular age-related macular degeneration, 2019
RHINE, (GR40398), A phase III, multicenter, randomized, double masked, active comparator-controlled study to evaluate the efficacy and safety of R06867461 (Faricimab) in patients with Diabetic Macular Edema, 2018
Safety and Efficacy of Suprachoroidal CLS-TA in Combination with an Intravitreal Anti-VEGF Agent in Subjects with Retinal Vein Occlusion, 2018
Sub-Investigator Protocols
LONGITUDE, (BP41783) A longitudinal, biomarker study of Anti-VEGF, to explore the relationship between aqueous humor composition and multimodal retinal imaging in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema, 2021
Lpath / Pfizer Pharmaceuticals, Sub-Investigator, Efficacy and Safety Study of iSONEP With and Without Lucentis/Avastin to Treat Age-related Macular Degeneration (AMD) (Nexus), 2014-2015.
XOMA, Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis (EYEGUARD™-A), 2014-2016.
XOMA, Sub-Investigator, Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled with Systemic Treatment (EYEGUARD™-C), 2014-2016.
XOMA, Sub-Investigator, An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data (EYEGUARD™-E), 2014-2015.
Santen, Sub-Investigator, A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis (SAKURA), 2015-2016.
LECTURES
Developments in the Management of Diabetic Retinopathy & Diabetic Macular Edema
2019 Glaucoma - Cataract Consultants, Inc. Annual Optometric CME Event
Vitreomacular Interface Disorders
2016 Prairie Eye Center Fall Optometric CME Symposium
The Evolving Role of Intravitreal Steroids in the Management of Diabetic Macular Edema
2016 University of Chicago Dept. of Ophthalmology and Visual Sciences Annual Research Day
Peripheral Retinal Pathology
2015 Illinois College of Optometry
Vitreoretinal Interface Disorders
2015 Glaucoma - Cataract Consultants, Inc. Annual Optometric CME Event
Peripheral Retinal Pathology
2015 Glaucoma - Cataract Consultants, Inc. Annual Optometric CME Event
>Vitreoretinal Interface Disorders,br>2014 University of Chicago Ophthalmology Residency Lecture Series
The Role of Vitreomacular Adhesion in Retinal Vascular and Neovascular Disease
2013 Wisconsin Academy of Ophthalmology Eye MD Symposium
Peripheral Retinal Pathology
2012 Wisconsin Optometric Association Summer Education Event
Diabetic Retinopathy
2012 Wisconsin Optometric Association Summer Education Event
Diabetic Retinopathy
2012 Aurora St. Luke's Family Practice Residency Lecture Series
Diabetic Retinopathy
2012 Aurora St. Luke's Endocrinology Group
Vitreoretinal Interface Disorders
2011 Northwestern University Ophthalmology Residency Lecture Series
Age-Related Macular Degeneration
2010 Northwestern University Ophthalmology Residency Lecture Series
Please visit the full website for Retina Partners Midwest for additional information: https://retinamidwest.com/